Мобильная версия

Доступно журналов:

3 288

Доступно статей:

3 891 637

 

Скрыть метаданые

Дата выпуска 1995
dc.description To assess factors that may influence the immunogenicity of oral poliovirus vaccine (OPV), neutralizing antibody responses were measured in 1409 infants in Brazil and the Gambia who were randomized to receive one offfour different formulations of OPV at ∼birth and at 6,10, and 14 weeks. Overall seroconversion rates at the end of the trial were 85% for poliovirus type 1 (PI), 94% for type 2 (P2), and 68% for type 3 (P3). Factors associated with vaccine failure included high levels of maternal antibody (PI, P2, and P3), vaccination during the rainy season (PI, P2, and P3), diarrhea at the time of vaccination (P2 and P3), household exposure to other OPV recipients (PI), and breast-feeding (P3) (P < .05 for each factor, logistic regression analysis). OPV containing twice the standard potency of Sabin type 1 virus increased seroconversion rates to PI by 8% in Brazil (P < .05) and 15% in the Gambia (P < .001). Suboptimal responses to OPV in developing countries are determined by a complex array of factors related to the vaccine, host, and environment.
Формат application.pdf
Издатель The University of Chicago Press
Копирайт © 1995 by The University of Chicago
Тема Major Articles
Название Factors Affecting the Immunogenicity of Oral Poliovirus Vaccine: A Prospective Evaluation in Brazil and the Gambia
Тип research-article
DOI 10.1093/infdis/171.5.1097
Electronic ISSN 1537-6613
Print ISSN 0022-1899
Журнал The Journal of Infectious Diseases
Том 171
Первая страница 1097
Последняя страница 1106
Аффилиация Department of Health, Natal, Rio Grande do Norte
Аффилиация Central Laboratory, Fundaçao de Saúde Amaury de Medeiros, Recife, Pernambuco
Аффилиация Ministry of Health, and Pan American Health Organization, Brasília, Brazil
Аффилиация Medical Research Council Laboratories, Fajara
Аффилиация Ministry of Health, Banjul, the Gambia
Аффилиация Expanded Programme on Immunization, World Health Organization, Geneva, Switzerland
Аффилиация Centers for Disease Control and Prevention, Atlanta, Georgia
Выпуск 5

Скрыть метаданые